BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 35989204)

  • 1. Discovery, classification, evolution and diversity of Siglecs.
    Angata T; Varki A
    Mol Aspects Med; 2023 Apr; 90():101117. PubMed ID: 35989204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
    Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
    Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs.
    Angata T
    Front Immunol; 2018; 9():2885. PubMed ID: 30564250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Genomic Events Altering Hominin SIGLEC Biology and Innate Immunity Predated the Common Ancestor of Humans and Archaic Hominins.
    Khan N; de Manuel M; Peyregne S; Do R; Prufer K; Marques-Bonet T; Varki N; Gagneux P; Varki A
    Genome Biol Evol; 2020 Jul; 12(7):1040-1050. PubMed ID: 32556248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs.
    Brinkman-Van der Linden EC; Sjoberg ER; Juneja LR; Crocker PR; Varki N; Varki A
    J Biol Chem; 2000 Mar; 275(12):8633-40. PubMed ID: 10722703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene conversions are frequent but not under positive selection in the Siglec gene families of primates.
    Zid M; Drouin G
    Genome; 2014 Jun; 57(6):317-25. PubMed ID: 25166301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Siglecs in Brain Function and Neurological Disorders.
    Siddiqui SS; Matar R; Merheb M; Hodeify R; Vazhappilly CG; Marton J; Shamsuddin SA; Al Zouabi H
    Cells; 2019 Sep; 8(10):. PubMed ID: 31546700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor.
    Sonnenburg JL; Altheide TK; Varki A
    Glycobiology; 2004 Apr; 14(4):339-46. PubMed ID: 14693915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
    Angata T; Hingorani R; Varki NM; Varki A
    J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates.
    Padler-Karavani V; Hurtado-Ziola N; Chang YC; Sonnenburg JL; Ronaghy A; Yu H; Verhagen A; Nizet V; Chen X; Varki N; Varki A; Angata T
    FASEB J; 2014 Mar; 28(3):1280-93. PubMed ID: 24308974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
    Linnartz-Gerlach B; Mathews M; Neumann H
    Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily.
    Patel N; Brinkman-Van der Linden EC; Altmann SW; Gish K; Balasubramanian S; Timans JC; Peterson D; Bell MP; Bazan JF; Varki A; Kastelein RA
    J Biol Chem; 1999 Aug; 274(32):22729-38. PubMed ID: 10428856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma.
    Santegoets KCM; Gielen PR; Büll C; Schulte BM; Kers-Rebel ED; Küsters B; Bossman SAJFH; Ter Laan M; Wesseling P; Adema GJ
    Cancer Immunol Immunother; 2019 Jun; 68(6):937-949. PubMed ID: 30953118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms.
    Angata T; Margulies EH; Green ED; Varki A
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13251-6. PubMed ID: 15331780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Siglec Signaling in the Tumor Microenvironment.
    van Houtum EJH; Büll C; Cornelissen LAM; Adema GJ
    Front Immunol; 2021; 12():790317. PubMed ID: 34966391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins.
    Brinkman-Van der Linden EC; Varki A
    J Biol Chem; 2000 Mar; 275(12):8625-32. PubMed ID: 10722702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-canonical roles of Siglecs: Beyond sialic acid-binding and immune cell modulation.
    Siddiqui SS
    Mol Aspects Med; 2023 Apr; 90():101145. PubMed ID: 36153172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Siglecs on autoimmune diseases.
    Brzezicka KA; Paulson JC
    Mol Aspects Med; 2023 Apr; 90():101140. PubMed ID: 36055802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.